Cargando…

Aberrant ROS Served as an Acquired Vulnerability of Cisplatin-Resistant Lung Cancer

Lung cancer has become a global health issue in recent decades. Approximately 80-85% of cases are non-small-cell lung cancer (NSCLC). Despite the high rate of resistance, cisplatin-base chemotherapy is still the main treatment for NSCLC patients. Thus, overcoming cisplatin resistance is urgently nee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xin, Qian, Ji, Qinghong, Zhang, Ying, Ma, Weihong, Tian, Baoqing, Liu, Yanli, Chen, Yunsong, Wang, Fei, Zhang, Ran, Wang, Xingwu, Yuan, Jupeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236771/ https://www.ncbi.nlm.nih.gov/pubmed/35770045 http://dx.doi.org/10.1155/2022/1112987

Ejemplares similares

Starvation-induced suppression of DAZAP1 by miR-10b integrates splicing control into TSC2-regulated oncogenic autophagy in esophageal squamous cell carcinoma
por: Chen, Yunsong, et al.
Publicado: (2020)

Exploiting the acquired vulnerability of cisplatin-resistant tumors with a hypoxia-amplifying DNA repair–inhibiting (HYDRI) nanomedicine
por: Chen, Jing, et al.
Publicado: (2021)

Deregulation of Exo70 Facilitates Innate and Acquired Cisplatin Resistance in Epithelial Ovarian Cancer by Promoting Cisplatin Efflux
por: Zhao, Yujie, et al.
Publicado: (2021)

Triptolide inhibits JAK2/STAT3 signaling and induces lethal autophagy through ROS generation in cisplatin-resistant SKOV3/DDP ovarian cancer cells
por: Zhong, Yanying, et al.
Publicado: (2021)

PIWI‐interacting RNAs are aberrantly expressed and may serve as novel biomarkers for diagnosis of lung adenocarcinoma
por: Li, Juan, et al.
Publicado: (2021)

Aberrant NRP-1 expression serves as predicator of metastatic endometrial and lung cancers
por: Okon, Imoh S., et al.
Publicado: (2015)

Editorial: Serving vulnerable and marginalized populations in social and educational contexts
por: Al-Hroub, Anies, et al.
Publicado: (2023)

Mitochondrial APE1 promotes cisplatin resistance by downregulating ROS in osteosarcoma
por: Liu, Yufeng, et al.
Publicado: (2020)

Cyanidin ameliorates cisplatin-induced cardiotoxicity via inhibition of ROS-mediated apoptosis
por: Qian, Peng, et al.
Publicado: (2018)

Aberrant Long Noncoding RNAs Expression Profiles Affect Cisplatin Resistance in Lung Adenocarcinoma
por: Hu, Lijuan, et al.
Publicado: (2017)

Aberrant methylation in neurofunctional gene serves as a hallmark of tumorigenesis and progression in colorectal cancer
por: Li, Xuan, et al.
Publicado: (2023)

The influence of genetic and acquired factors on the vulnerability to develop depression: a review
por: Zhang, Xingfang, et al.
Publicado: (2023)

Methionine orchestrates the metabolism vulnerability in cisplatin resistant bladder cancer microenvironment
por: Yang, Chen, et al.
Publicado: (2023)

NAMPT/SIRT1 Attenuate Ang II-Induced Vascular Remodeling and Vulnerability to Hypertension by Inhibiting the ROS/MAPK Pathway
por: Zhou, Lei, et al.
Publicado: (2020)

Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway
por: Wei, Xuan, et al.
Publicado: (2021)

Increased Autophagy Levels Mediate Cisplatin Resistance in Cisplatin-Resistant Cells While Also Rendering Them Vulnerable to Autophagy Induction
por: Duan, Guihua, et al.
Publicado: (2018)

Piperlongumine increases the sensitivity of bladder cancer to cisplatin by mitochondrial ROS
por: Pan, Xiaobo, et al.
Publicado: (2022)

Pyrocatechol Alleviates Cisplatin-Induced Acute Kidney Injury by Inhibiting ROS Production
por: Xie, Xuexia, et al.
Publicado: (2022)

The genetic vulnerability to cisplatin ototoxicity: a systematic review
por: Tserga, Evangelia, et al.
Publicado: (2019)

Epigenetic aging is associated with aberrant neural oscillatory dynamics serving visuospatial processing in people with HIV
por: Schantell, Mikki, et al.
Publicado: (2022)

ROS-Induced DCTPP1 Upregulation Contributes to Cisplatin Resistance in Ovarian Cancer
por: Wang, Yu, et al.
Publicado: (2022)

Mammography facilities serving vulnerable women have longer follow‐up times
por: Karliner, Leah S., et al.
Publicado: (2018)

IDO1 Modulates the Sensitivity of Epithelial Ovarian Cancer Cells to Cisplatin through ROS/p53-Dependent Apoptosis
por: Wang, Houmei, et al.
Publicado: (2022)

MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway
por: Lin, Zhilai, et al.
Publicado: (2020)

Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway
por: Wei, Xuan, et al.
Publicado: (2021)

ROS-Induced SIRT2 Upregulation Contributes to Cisplatin Sensitivity in Ovarian Cancer
por: Wang, Wenyu, et al.
Publicado: (2020)

Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer
por: Wangpaichitr, Medhi, et al.
Publicado: (2017)

Cisplatin Resistance and Redox-Metabolic Vulnerability: A Second Alteration
por: Wangpaichitr, Medhi, et al.
Publicado: (2021)

Refugee and Migrant Children’s Mental Healthcare: Serving the Voiceless, Invisible, and the Vulnerable Global Citizens
por: Khan, Farah, et al.
Publicado: (2020)

Emodin Augments Cisplatin Cytotoxicity in Platinum-Resistant Ovarian Cancer Cells via ROS-Dependent MRP1 Downregulation
por: Ma, Jun, et al.
Publicado: (2014)

Salivary Fusobacterium nucleatum serves as a potential biomarker for colorectal cancer
por: Zhang, Xin, et al.
Publicado: (2022)

Aberrant cholesterol metabolism in colorectal cancer represents a targetable vulnerability
por: Xie, Jingwu, et al.
Publicado: (2022)

Aberrant Upregulation of 14-3-3σ and EZH2 Expression Serves as an Inferior Prognostic Biomarker for Hepatocellular Carcinoma
por: Zhang, Yi, et al.
Publicado: (2014)

MicroRNA-95-3p serves as a contributor to cisplatin resistance in human gastric cancer cells by targeting EMP1/PI3K/AKT signaling
por: Ni, Qingfeng, et al.
Publicado: (2021)

Plumbagin Enhances the Anticancer Efficacy of Cisplatin by Increasing Intracellular ROS in Human Tongue Squamous Cell Carcinoma
por: Xue, Danfeng, et al.
Publicado: (2020)

An enhanced antioxidant strategy of astaxanthin encapsulated in ROS-responsive nanoparticles for combating cisplatin-induced ototoxicity
por: Gu, Jiayi, et al.
Publicado: (2022)

Ribosomal protein L10 in mitochondria serves as a regulator for ROS level in pancreatic cancer cells
por: Yang, Jun, et al.
Publicado: (2018)

Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS
por: Qu, Xianzhi, et al.
Publicado: (2017)

Methamphetamine exposure drives cell cycle exit and aberrant differentiation in rat hippocampal-derived neurospheres
por: Wang, Shaomin, et al.
Publicado: (2023)

Exosomal Cripto-1 Serves as a Potential Biomarker for Perihilar Cholangiocarcinoma
por: Hu, Chunxiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1liv1b2p6n5o51innclvf9393k